Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05082935 · ClinicalTrials.gov registry record · NA
COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos) Phase II
A NA study, sponsored by University of Oregon.
- Completed
- Registry status
- NA
- Development phase
- 1,463
- Enrollment target
NCT05082935 is a NA study that has completed, run by University of Oregon. The registered enrollment target is 1,463 participants.
The verdict
NCT05082935, a NA study, has completed, sponsored by University of Oregon.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,463 participants
- Enrollment target
Study Summary
The global SARS-CoV-2 pandemic that causes the severe respiratory illness COVID-19 is the worst health crisis that the United States has faced in a century. Although this highly contagious virus has infected millions of Americans already, the disease burdens are disproportionately born by historically underserved populations such as Latinx communities. In Oregon, 13% of the population that is Latinx represents approximately 25.7% of COVID-19 cases and are burdened with more than twice the cases per 100,000 individuals compared to non-Hispanic Oregonians (10,677 versus 4,616, respectively). Furthermore, only 54.9% of eligible Latinx Oregonians are vaccinated compared to the 76.2% statewide vaccination rate. An urgent need exists to reach Oregon's Latinx community to prevent SARS-CoV-2 transmission and increase vaccine acceptance. The overall goal of this study is to implement a Promotores de Salud behavioral health intervention to increase the reach, access, uptake, and impact of testing and vaccination in Latinx communities in Oregon. This project will fully integrate with the National institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) consortium and its Coordination and Data Collection Center (CDCC). The study team will add testing venues based on feedback from the Oregon Health Authority (OHA) and our county and community partners to test if a "partner-optimized venue placement strategy" yields more Latinx individuals tested than placement of sites based upon residential density used in the ongoing testing in Phase I of this study (Clinical Trial ID: NCT04793464). In addition, evaluation of the Promotores de Salud intervention held during testing events will test whether culturally competent education results in greater use of strategies that reduce transmission of COVID-19 at the community and individual level and increases the number of individuals who choose to be vaccinated, as a function of fidelity of the intervention. Over time, this proje
Interventions
- BEHAVIORAL Phase II Promotores de Salud
- BEHAVIORAL Phase I Promotores de Salud Outreach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,463 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2023-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05082935
The ClinicalTrials.gov registry entry for NCT05082935 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,463 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oregon, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Phase II Promotores de Salud is the first listed.
NCT05082935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05082935 about?
NCT05082935 is a clinical study titled "COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos) Phase II". The global SARS-CoV-2 pandemic that causes the severe respiratory illness COVID-19 is the worst health crisis that the United States has faced in a century. Although this highly contagious virus has infected millions of Americans already, the disease burdens are disproportionately born by historical...
What is the current status of trial NCT05082935?
This trial is currently completed. It is a NA study. The enrollment target is 1,463 participants. The study started on 2021-09-15. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT05082935?
The interventions under investigation include: Phase II Promotores de Salud (BEHAVIORAL), Phase I Promotores de Salud Outreach (BEHAVIORAL).
Who is sponsoring clinical trial NCT05082935?
This trial is sponsored by University of Oregon, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.